AbstractAs negative regulators of receptor tyrosine kinase-mediated signalling, Sprouty proteins fulfil important roles during carcinogenesis. In this report, we demonstrate that Sprouty2 protein expression inhibits cell proliferation and migration in osteosarcoma-derived cells. Although earlier reports describe a tumour-promoting function, these results indicate that Sprouty proteins also have the potential to function as tumour suppressors in sarcoma. In contrast to Sprouty2, Sprouty4 expression failed to interfere with proliferation and migration of the osteosarcoma-derived cells, possibly due to a less pronounced interference with mitogen-activated protein kinase activity. Sequences within the NH2-terminus are responsible for the specif...
Resistance to trastuzumab is a clinical problem, partly due to overriding activation of MAPK/PI3K si...
Sprouty2 is a feedback regulator that controls the Ras/Raf/MEK/extracellular signal-regulated kinase...
[[abstract]]Sprouty2 (SPRY2) is known to inhibit the RAS/MAPK/ERK pathway, and is a potential study ...
Sprouty Proteine spielen eine wichtige Rolle in der Regulation von Signaltransduktion. Über untersch...
Graduate Program in Science for Aging/박사Sprouty2 proteins function as inhibitors of receptor tyrosin...
Background: Sprouty2 (SPRY2), a feedback regulator of receptor tyrosine kinase (RTK) signaling, has ...
Sprouty (Spry) proteins function as inhibitors of receptor tyrosine kinase signaling mainly by inter...
BACKGROUND: Cancer stem cells contribute to tumor initiation, heterogeneity, and recurrence, and are...
AbstractSprouty (SPRY) proteins are well-characterized factors that inhibit receptor tyrosine kinase...
We demonstrate that pre-treatment of estrogen receptor negative MDA-MB-231 breast cancer cells conta...
Resistance to trastuzumab is a clinical problem, partly due to overriding activation of MAPK/PI3K si...
Background: Resistance to trastuzumab is a clinical problem, partly due to overriding activation of ...
Sprouty proteins act ubiquitously as signaling integrators and inhibitors of receptor tyrosine kinas...
Every three minutes in the United States a woman is diagnosed with breast cancer. The current thera...
The Sprouty proteins are increasingly being recognized to be deregulated in various types of cancers...
Resistance to trastuzumab is a clinical problem, partly due to overriding activation of MAPK/PI3K si...
Sprouty2 is a feedback regulator that controls the Ras/Raf/MEK/extracellular signal-regulated kinase...
[[abstract]]Sprouty2 (SPRY2) is known to inhibit the RAS/MAPK/ERK pathway, and is a potential study ...
Sprouty Proteine spielen eine wichtige Rolle in der Regulation von Signaltransduktion. Über untersch...
Graduate Program in Science for Aging/박사Sprouty2 proteins function as inhibitors of receptor tyrosin...
Background: Sprouty2 (SPRY2), a feedback regulator of receptor tyrosine kinase (RTK) signaling, has ...
Sprouty (Spry) proteins function as inhibitors of receptor tyrosine kinase signaling mainly by inter...
BACKGROUND: Cancer stem cells contribute to tumor initiation, heterogeneity, and recurrence, and are...
AbstractSprouty (SPRY) proteins are well-characterized factors that inhibit receptor tyrosine kinase...
We demonstrate that pre-treatment of estrogen receptor negative MDA-MB-231 breast cancer cells conta...
Resistance to trastuzumab is a clinical problem, partly due to overriding activation of MAPK/PI3K si...
Background: Resistance to trastuzumab is a clinical problem, partly due to overriding activation of ...
Sprouty proteins act ubiquitously as signaling integrators and inhibitors of receptor tyrosine kinas...
Every three minutes in the United States a woman is diagnosed with breast cancer. The current thera...
The Sprouty proteins are increasingly being recognized to be deregulated in various types of cancers...
Resistance to trastuzumab is a clinical problem, partly due to overriding activation of MAPK/PI3K si...
Sprouty2 is a feedback regulator that controls the Ras/Raf/MEK/extracellular signal-regulated kinase...
[[abstract]]Sprouty2 (SPRY2) is known to inhibit the RAS/MAPK/ERK pathway, and is a potential study ...